Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 8/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12441707 | 0.78 | TET2 (0.48) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL27075567 | 0.76 | BBOX1 (1.00) | BBOX1CA1GPR84SLC22A16CA2 | |
| Carbamic Acid SCHEMBL2521121 | 0.73 | NFKB1 (0.43) | BBOX1CA1GPR84SLC22A16CA2 | |
| Tetramethylammonium Ion SCHEMBL8437282 | 0.71 | BBOX1 (0.56) | BBOX1CA1GPR84CA2FFAR3 | |
| SCHEMBL21983247 | 0.71 | GPR84 (0.52) | BBOX1CA1GPR84SLC22A16CA2 | |
| Octanoic Acid SCHEMBL28145198 | 0.70 | FABP3 (0.53) | CA1GPR84NFKB1 | |
| SCHEMBL31387898 | 0.70 | CA1 (0.64) | BBOX1CA1GPR84CA2FFAR3 | |
| SCHEMBL311418 | 0.70 | — | — | |
| Lithium Ion SCHEMBL11690140 | 0.70 | — | — | |
| SCHEMBL28674846 | 0.70 | CA1 (0.64) | BBOX1CA1GPR84CA2FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3166639-B1 | METHODS FOR EVALUATING FOOD AND FEEDING SYSTEM FOR THE PREVENTION AND TREATMENT OF CHRONIC DISEASES | EGB EPIGENETICBALANCE AG (CH) | 2020-03-25 | — | — | EP | disclosed |
| EP-3166639-A1 | METHOD FOR EVALUATING FOODS, AND NUTRITIONAL SYSTEM FOR THE PREVENTION AND TREATMENT OF CHRONIC DISEASES | EGB EpiGeneticBalance AG (CH) | 2017-05-17 | — | — | EP | disclosed |
| WO-2016005425-A1 | METHOD FOR EVALUATING FOODS, AND NUTRITIONAL SYSTEM FOR THE PREVENTION AND TREATMENT OF CHRONIC DISEASES | EGB EPIGENETICBALANCE AG (CH) | 2016-01-14 | — | — | WO | disclosed |
| US-20120148685-A1 | METHODS AND COMPOSITIONS FOR TREATING INSULIN RESISTANCE, DIABETES MELLITUS TYPE 2, METABOLIC SYNDROME AND RELATED DISORDERS | Engergy4Life AG (CH) | 2012-06-14 | — | — | US | disclosed |
| EP-2440201-A1 | METHODS AND COMPOSITIONS FOR TREATING INSULIN RESISTANCE, DIABETES MELLITUS TYPE 2, METABOLIC SYNDROME AND RELATED DISORDERS | Energy4life Ag (CH) | 2012-04-18 | — | — | EP | disclosed |
| EP-1962826-B1 | METHOD FOR WEIGHT REDUCTION | ENERGY4LIFE GMBH (CH) | 2011-11-16 | — | — | EP | disclosed |
| US-20110261737-A1 | TRANSMIT AND RECEIVE METHOD FOR A DATA SERVICE | AT&T Intellectual Property II, L.P. (formerly known as AT&T CORP.) (US) | 2011-10-27 | — | — | US | disclosed |
| WO-2010143053-A1 | METHODS AND COMPOSITIONS FOR TREATING INSULIN RESISTANCE, DIABETES MELLITUS TYPE 2, METABOLIC SYNDROME AND RELATED DISORDERS | ENERGY4LIFE AG (CH) | 2010-12-16 | — | — | WO | disclosed |
| US-20090081320-A1 | Method for Weight Reduction | ENERGY4LIFE AG (CH) | 2009-03-26 | — | — | US | disclosed |